Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Chaity Chaudhury, Samina Mehnaz, John M. Robinson et al. · The Journal of Experimental Medicine · 2003 · 637 citations · Full text

Life Sciences, Biochemistry, Immunology +14

Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice

Erika Cretney, Kazuyoshi Takeda, Hideo Yagita∥ et al. · The Journal of Immunology · 2002 · 592 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety

Sean K. Kelley, Louise A. Harris, David Xie et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 443 citations

Life Sciences, Oncology, Pharmacology +17

Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer

Roy S. Herbst, S. Gail Eckhardt, Razelle Kurzrock et al. · Journal of Clinical Oncology · 2010 · 440 citations

Life Sciences, Oncology, Pharmacology +17

Engineering of a femtomolar affinity binding protein to human serum albumin

Anders Jönsson, Jakob Dogan, Nina Herne et al. · Protein Engineering Design and Selection · 2008 · 228 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17